This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased…
Three Taxotere hair loss lawsuits have been selected to serve as potential fourth bellwether trials over claims the chemotherapy drug's manufacturers failed to warn patients of the risk of permanent…
A federal judge, after denying a flurry of summary judgment requests, has delayed the next Taxotere hair loss bellwether lawsuit, which was slated to go to trial in February.
French authorities are pursuing a manslaughter investigation against Sanofi, following the deaths of four infants who died of birth defects linked to the epilepsy drug, Depakine.
A federal judge has dismissed nearly 200 Taxotere lawsuits for being filed after the manufacturer added a warning to the label about permanent hair loss risks, but indicated the bulk…
Four bellwether trials over Taxotere hair loss claims will be held over the next two years, a federal judge has ordered.
A Zantac lawsuit indicates that high levels of NDMA in the heartburn drug resulted in a gastric cancer diagnosis.
A Zantac class action lawsuit calls for manufacturers to pay for the medical monitoring of anyone who took the drugs long-term and now faces an increased risk of cancer.
A Zantac lawsuit claims the recalled heartburn drugs caused a case of esophageal cancer due to NDMA contamination.
A Zantac class action lawsuit claims manufacturers of the heartburn drug knowingly sold potentially cancer-causing drugs to the public for decades.
